The use of evidence in pharmacovigilance: Case reports as the reference source for drug withdrawals

European Journal of Clinical Pharmacology

Volumn 57, Issue 1, 2001, Pages 89-91

  Arnaiz, J A ^a   Carne X ^a   Riba, N ^a   Codina, C ^a   Ribas, J ^a   Trilla, A ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Adverse drug reaction; Drug withdrawal; Pharmacovigilane

Indexed keywords

AMINEPTINE; BENDAZAC; CENTOXIN; CHLORMEZANONE; CINCHOPHEN; DEXFENFLURAMINE; DROXICAM; EBROTIDINE; FENFLURAMINE; GLAFENINE; GREPAFLOXACIN; IMMUNOGLOBULIN; MIBEFRADIL; MINAPRINE; MONOSIALOGANGLIOSIDE; NAFTIDROFURYL; PIRPROFEN; PYRITHYLDIONE; SERTINDOLE; TERODILINE; TOLCAPONE; TROVAFLOXACIN; ZIPEPROL;

ADVERSE DRUG REACTION; CASE CONTROL STUDY; CLINICAL TRIAL; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; REVIEW;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CLINICAL TRIALS; DATABASES, FACTUAL; HUMANS;

EID: 0035038538     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280100265     Document Type: Review

References (10)

1. Critical appraisal of published research: Introductory guidelines
2. Identification of adverse reactions to new drugs. III: Alerting processes and early warning systems
3. Pathogenesis of adverse drug reactions
4. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs
5. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: Population based case-control study
6. Effect of different progestogens in low oestrogen oral contraceptives on venous thromboembolic disease
7. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism women using oral contraceptives with differing progestagen components
8. Third generation oral contraceptives and risk of venous thromboembolic disorders: An international case-control study
9. Fatal aplastic anaemia associated with nifedipine
10. Methodological and political issues in clinical pharmacology research by the year 2000